T cell epitope-based allergy vaccines

Current Topics in Microbiology and Immunology

Volumn 352, Issue 1, 2011, Pages 107-119

  Larché, Mark ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; API M 1; BEE VENOM; EPITOPE; PEPTIDE IPC 1 PLUS PEPTIDE IPC 2; PEPTIDE VACCINE; PEPTIDE VACCINE API M 1; PEPTIDE VACCINE FEL D 1; PLACEBO; UNCLASSIFIED DRUG; API M 1 ALLERGEN; FEL D 1 ALLERGEN; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; T CELL EPITOPE BASED ALLERGY VACCINE; VACCINE;

ABSENCE OF SIDE EFFECTS; ALLERGENICITY; ALLERGIC REACTION; ALLERGY; ANTIGEN SPECIFICITY; ARTICLE; ASTHMA; B LYMPHOCYTE; BEE VENOM ALLERGY; CAT ALLERGY; CELLULAR IMMUNITY; CHEST TIGHTNESS; CLINICAL EFFECTIVENESS; CROSS REACTION; DRUG MEGADOSE; EFFECTOR CELL; HUMAN; IMMUNOGENICITY; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; IMMUNOTHERAPY; NONHUMAN; PRIORITY JOURNAL; PRURITUS; RHINITIS; T LYMPHOCYTE; UNSPECIFIED SIDE EFFECT; WHEEZING; ALLERGIC RHINITIS; BRONCHUS HYPERREACTIVITY; CELL SPECIFICITY; CLINICAL STUDY; DELAYED HYPERSENSITIVITY; DESENSITIZATION; DOMESTIC ANIMAL ALLERGY; DRUG DESIGN; DRUG DOSE ESCALATION; IMMUNOGLOBULIN BLOOD LEVEL; INSECT VENOM ALLERGY; LOW DRUG DOSE; MAJOR HISTOCOMPATIBILITY COMPLEX; OUTCOME ASSESSMENT; PLACEBO EFFECT; TREATMENT OUTCOME;

ANIMALS; ARTHROPOD VENOMS; CATS; DESENSITIZATION, IMMUNOLOGIC; EPITOPES, T-LYMPHOCYTE; HUMANS; HYPERSENSITIVITY; INSECT PROTEINS; MICE; PEPTIDES; T-LYMPHOCYTES; VACCINES, SUBUNIT;

APOIDEA;

EID: 80053546277     PISSN: 0070217X     EISSN: None     Source Type: Book Series    
DOI: 10.1007/82_2011_131     Document Type: Article

References (51)

1. Alexander C, Ying S, Kay B, Larche M (2005) Fel d 1-derived T cell peptide therapy induces recruitment of CD4CD25; CD4 interferon-gamma T helper type 1 cells to sites of allergen-induced late-phase skin reactions in cat-allergic subjects. Clin Exp Allergy 35(1):52-58 (Pubitemid 40188270)
2. Ali FR, Oldfield WL, Higashi N, Larche M, Kay AB (2004) Late asthmatic reactions induced by inhalation of allergen-derived T cell peptides. Am J Respir Crit Care Med 169(1):20-26 (Pubitemid 38233884)
3. Anderton SM, Burkhart C, Liu GY, Metzler B, Wraith DC (1998) Antigen-specific tolerance induction and the immunotherapy of experimental autoimmune disease. Novartis Found Symp 215:120-131
4. Apostolou I, Von Boehmer H (2004) In vivo instruction of suppressor commitment in naive T cells. J Exp Med 199(10):1401-1408 (Pubitemid 38685731)
5. Bal V, McIndoe A, Denton G, Hudson D, Lombardi G, Lamb J et al (1990) Antigen presentation by keratinocytes induces tolerance in human T cells. Eur J Immunol 20(9):1893-1897 (Pubitemid 20355608)
6. Bauer L, Bohle B, Jahn-Schmid B, Wiedermann U, Daser A, Renz H et al (1997) Modulation of the allergic immune response in BALB/c mice by subcutaneous injection of high doses of the dominant T cell epitope from the major birch pollen allergen Bet v 1. Clin Exp Immunol 107(3):536-541 (Pubitemid 27102143)
7. Bockova J, Elias D, Cohen IR (1997) Treatment of NOD diabetes with a novel peptide of the hsp60 molecule induces Th2-type antibodies. J Autoimmun 10(4):323-329 (Pubitemid 27366137)
8. Briner TJ, Kuo MC, Keating KM, Rogers BL, Greenstein JL (1993) Peripheral T-cell tolerance induced in naive and primed mice by subcutaneous injection of peptides from the major cat allergen Fel d I. Proc Natl Acad Sci USA 90(16):7608-7612 (Pubitemid 23249999)
9. Burkhart C, Liu GY, Anderton SM, Metzler B, Wraith DC (1999) Peptide-induced T cell regulation of experimental autoimmune encephalomyelitis: a role for IL-10. Int Immunol 11(10):1625-1634 (Pubitemid 29481729)
10. Campbell JD, Buckland KF, McMillan SJ, Kearley J, Oldfield WL, Stern LJ et al (2009) Peptide immunotherapy in allergic asthma generates IL-10-dependent immunological tolerance associated with linked epitope suppression. J Exp Med 206(7):1535-1547
11. Carneiro R, Reefer A, Wilson B, Hammer J, Platts-Mills T, Custis N et al (2004) T cell epitope-specific defects in the immune response to cat allergen in patients with atopic dermatitis. J Invest Dermatol 122(4):927-936 (Pubitemid 38580995)
12. Chai JG, James E, Dewchand H, Simpson E, Scott D (2004) Transplantation tolerance induced by intranasal administration of HY peptides. Blood 103(10):3951-3959 (Pubitemid 38596318)
13. Clayton JP, Gammon GM, Ando DG, Kono DH, Hood L, Sercarz EE (1989) Peptide-specific prevention of experimental allergic encephalomyelitis. Neonatal tolerance induced to the dominant T cell determinant of myelin basic protein J Exp Med 169(5):1681-1691 (Pubitemid 19126825)
14. Critchfield JM, Racke MK, Zuniga-Pflucker JC, Cannella B, Raine CS, Goverman J et al (1994) T cell deletion in high antigen dose therapy of autoimmune encephalomyelitis. Science 263(5150):1139-1143 (Pubitemid 24105960)
15. Daniel D, Wegmann DR (1996) Protection of nonobese diabetic mice from diabetes by intranasal or subcutaneous administration of insulin peptide B-(9-23). Proc Natl Acad Sci USA 93(2):956-960 (Pubitemid 26041202)
16. Durham SR, Walker SM, Varga EM, Jacobson MR, O'Brien F, Noble W et al (1999) Long-term clinical efficacy of grass-pollen immunotherapy. N Engl J Med 341(7):468-475 (Pubitemid 29372886)
17. Fellrath JM, Kettner A, Dufour N, Frigerio C, Schneeberger D, Leimgruber A et al (2003) Allergen-specific T-cell tolerance induction with allergen-derived long synthetic peptides: results of a phase I trial. J Allergy Clin Immunol 111(4):854-861 (Pubitemid 36470260)
18. Gammon G, Dunn K, Shastri N, Oki A, Wilbur S, Sercarz EE (1986) Neonatal T-cell tolerance to minimal immunogenic peptides is caused by clonal inactivation. Nature 319(6052):413-415 (Pubitemid 16163902)
19. Gaur A, Wiers B, Liu A, Rothbard J, Fathman CG (1992) Amelioration of autoimmune encephalomyelitis by myelin basic protein synthetic peptide-induced anergy. Science 258(5087):1491-1494 (Pubitemid 23011006)
20. Haselden BM, Kay AB, Larche M (1999) Immunoglobulin E-independent major histocompat-ibility complex-restricted T cell peptide epitope-induced late asthmatic reactions. J Exp Med 189(12):1885-1894 (Pubitemid 29295887)
21. Hoyne GF, O'Hehir RE, Wraith DC, Thomas WR, Lamb JR (1993) Inhibition of T cell and antibody responses to house dust mite allergen by inhalation of the dominant T cell epitope in naive and sensitized mice. J Exp Med 178(5):1783-1788 (Pubitemid 23318458)
22. Karin N, Mitchell DJ, Brocke S, Ling N, Steinman L (1994) Reversal of experimental autoimmune encephalomyelitis by a soluble peptide variant of a myelin basic protein epitope: T cell receptor antagonism and reduction of interferon gamma and tumor necrosis factor alpha production. J Exp Med 180(6):2227-2237
23. Kearney ER, Pape KA, Loh DY, Jenkins MK (1994) Visualization of peptide-specific T cell immunity and peripheral tolerance induction in vivo. Immunity 1(4):327-339
24. King TP, Lu G, Agosto H (1998) Antibody responses to bee melittin (Api m 4) and hornet antigen 5 (Dol m 5) in mice treated with the dominant T-cell epitope peptides. J Allergy Clin Immunol 101(3):397-403 (Pubitemid 28146361)
25. Kretschmer K, Apostolou I, Hawiger D, Khazaie K, Nussenzweig MC, Von Boehmer H (2005) Inducing and expanding regulatory T cell populations by foreign antigen. Nat Immunol 6:152-162
26. Ku G, Kronenberg M, Peacock DJ, Tempst P, Banquerigo ML, Braun BS et al (1993) Prevention of experimental autoimmune arthritis with a peptide fragment of type II collagen. Eur J Immunol 23(3):591-599 (Pubitemid 23095089)
27. Lamb JR, Skidmore BJ, Green N, Chiller JM, Feldmann M (1983) Induction of tolerance in influenza virus-immune T lymphocyte clones with synthetic peptides of influenza hemagglutinin. J Exp Med 157(5):1434-1447 (Pubitemid 13088987)
28. Maguire P, Nicodemus C, Robinson D, Aaronson D, Umetsu DT (1999) The safety and efficacy of ALLERVAX CAT in cat allergic patients. Clin Immunol 93(3):222-231
29. Marcotte GV, Braun CM, Norman PS, Nicodemus CF, Kagey-Sobotka A, Lichtenstein LM et al (1998) Effects of peptide therapy on ex vivo T-cell responses. J Allergy Clin Immunol 101(4 Pt 1):506-513 (Pubitemid 28208255)
30. Metzler B, Wraith DC (1993) Inhibition of experimental autoimmune encephalomyelitis by inhalation but not oral administration of the encephalitogenic peptide: influence of MHC binding affinity. Int Immunol 5(9):1159-1165 (Pubitemid 23291165)
31. Muller U, Akdis CA, Fricker M, Akdis M, Blesken T, Bettens F et al (1998) Successful immunotherapy with T-cell epitope peptides of bee venom phospholipase A2 induces specific T-cell anergy in patients allergic to bee venom. J Allergy Clin Immunol 101(6 Pt 1):747-754
32. Norman PS, Ohman JL, Long AA, Creticos PS, Gefter MA, Shaked Z et al (1996) Treatment of cat allergy with T-cell reactive peptides. Am J Respir Crit Care Med 154(6 Pt 1):1623-1628 (Pubitemid 26424925)
33. Novak N, Bieber T, Katoh N (2001) Engagement of Fc epsilon RI on human monocytes induces the production of IL-10 and prevents their differentiation in dendritic cells. J Immunol 167(2):797-804 (Pubitemid 32660834)
34. Oldfield WL, Kay AB, Larche M (2001) Allergen-derived T cell peptide-induced late asthmatic reactions precede the induction of antigen-specific hyporesponsiveness in atopic allergic asthmatic subjects. J Immunol 167(3):1734-1739 (Pubitemid 32703177)
35. Oldfield WL, Larche M, Kay AB (2002) Effect of T-cell peptides derived from Fel d 1 on allergic reactions and cytokine production in patients sensitive to cats: a randomised controlled trial. Lancet 360(9326):47-53 (Pubitemid 34756492)
36. Pene J, Desroches A, Paradis L, Lebel B, Farce M, Nicodemus CF et al (1998) Immunotherapy with Fel d 1 peptides decreases IL-4 release by peripheral blood T cells of patients allergic to cats. J Allergy Clin Immunol 102(4 Pt 1):571-578 (Pubitemid 28487932)
37. Prakken BJ, van Der ZR, Anderton SM, van Kooten PJ, Kuis W, van Eden W (1997) Peptide-induced nasal tolerance for a mycobacterial heat shock protein 60 T cell epitope in rats suppresses both adjuvant arthritis and nonmicrobially induced experimental arthritis. Proc Natl Acad Sci USA 94(7):3284-3289
38. Reefer AJ, Carneiro RM, Custis NJ, Platts-Mills TA, Sung SS, Hammer J et al (2004) A role for IL-10-mediated HLA-DR7-restricted T cell-dependent events in development of the modified Th2 response to cat allergen. J Immunol 172(5):2763-2772 (Pubitemid 38263659)
39. Santambrogio L, Sato AK, Fischer FR, Dorf ME, Stern LJ (1999a) Abundant empty class II MHC molecules on the surface of immature dendritic cells. Proc Natl Acad Sci USA 96(26):15050-15055 (Pubitemid 30019763)
40. Santambrogio L, Sato AK, Carven GJ, Belyanskaya SL, Strominger JL, Stern LJ (1999b) Extracellular antigen processing and presentation by immature dendritic cells. Proc Natl Acad Sci USA 96(26):15056-15061 (Pubitemid 30019764)
41. Simons FE, Imada M, Li Y, Watson WT, HayGlass KT (1996) Fel d 1 peptides: effect on skin tests and cytokine synthesis in cat-allergic human subjects. Int Immunol 8(12):1937-1945 (Pubitemid 27007744)
42. Smith TR, Alexander C, Kay AB, Larche M, Robinson DS (2004) Cat allergen peptide immunotherapy reduces CD4 T cell responses to cat allergen but does not alter suppression by CD4 CD25 T cells: a double-blind placebo-controlled study. Allergy 59(10):1097-1101 (Pubitemid 39279108)
43. Staines NA, Harper N, Ward FJ, Malmstrom V, Holmdahl R, Bansal S (1996) Mucosal tolerance and suppression of collagen-induced arthritis (CIA) induced by nasal inhalation of synthetic peptide 184-198 of bovine type II collagen (CII) expressing a dominant T cell epitope. Clin Exp Immunol 103(3):368-375 (Pubitemid 26089942)
44. Steinman RM, Hawiger D, Nussenzweig MC (2003) Tolerogenic dendritic cells. Annu Rev Immunol 21:685-711. (Pubitemid 37174545)
45. Tarzi M, Klunker S, Texier C, Verhoef A, Stapel SO, Akdis C et al (2005) Induction of interleukin-10 and suppressor of cytokine signaling-3 gene expression following peptide immunotherapy. Clin Exp Allergy
46. Texier C, Pouvelle S, Busson M, Herve M, Charron D, Menez A et al (2000) HLA-DR restricted peptide candidates for bee venom immunotherapy. J Immunol 164(6):3177-3184 (Pubitemid 30148979)
47. Tian J, Atkinson MA, Clare-Salzler M, Herschenfeld A, Forsthuber T, Lehmann PV et al (1996) Nasal administration of glutamate decarboxylase (GAD65) peptides induces Th2 responses and prevents murine insulin-dependent diabetes. J Exp Med 183(4):1561-1567 (Pubitemid 26134299)
48. Verhoef A, Alexander C, Kay AB, Larche M (2005) T cell epitope immunotherapy induces a CD4(+) T cell population with regulatory activity. PLoS Med 2(3):e78
49. Von Garnier C, Astori M, Kettner A, Dufour N, Heusser C, Corradin G et al (2000) Allergen-derived long peptide immunotherapy down-regulates specific IgE response and protects from anaphylaxis. Eur J Immunol 30(6):1638-1645 (Pubitemid 30342806)
50. Wraith DC, Goldman M, Lambert PH (2003) Vaccination and autoimmune disease: what is the evidence? Lancet 362(9396):1659-1666 (Pubitemid 37443537)
51. Wraith DC, Nicolson KS, Whitley NT (2004) Regulatory CD4(+) T cells and the control of autoimmune disease. Curr Opin Immunol 16(6):695-701 (Pubitemid 39423656)